Lipid peroxidation and tyrosine nitration in traumatic brain injury: Insights into secondary injury from redox proteomics

被引:24
作者
Butterfield, D. Allan [1 ,2 ,3 ]
Reed, Tanea T. [4 ]
机构
[1] Univ Kentucky, Dept Chem, Lexington, KY 40506 USA
[2] Univ Kentucky, Spinal Cord & Brain Injury Res Ctr, Lexington, KY USA
[3] Univ Kentucky, Sanders Brown Ctr Aging, Lexington, KY 40506 USA
[4] Eastern Kentucky Univ, Dept Chem, Richmond, KY 40475 USA
关键词
mass spectrometry; traumatic brain injury; oxidative stress; MEDIATED CYTOSKELETAL DEGRADATION; PROFESSIONAL FOOTBALL PLAYERS; SPECTRIN BREAKDOWN PRODUCTS; MILD COGNITIVE IMPAIRMENT; NEURON-SPECIFIC ENOLASE; ALZHEIMERS-DISEASE; CEREBROSPINAL-FLUID; OXIDATIVE STRESS; SUPEROXIDE-DISMUTASE; L-ARGININE;
D O I
10.1002/prca.201600003
中图分类号
Q5 [生物化学];
学科分类号
071010 ; 081704 ;
摘要
Traumatic brain injury (TBI) is a spontaneous event in which sudden trauma and secondary injury cause brain damage. Symptoms of TBI can range from mild to severe depending on extent of injury. The outcome can span from complete patient recovery to permanent memory loss and neurological decline. Currently, there is no known cure for TBI; however, immediate medical attention after injury is most beneficial for patient recovery. It is a well-established concept that imbalances in the production of reactive oxygen species (ROS), reactive nitrogen species (RNS), and native antioxidant mechanisms have been shown to increase oxidative stress. Over the years, proteomics has been used to identify specific biomarkers in diseases such as cancers and neurological disorders such as Alzheimer disease and Parkinson disease. As TBI is a risk factor for a multitude of neurological diseases, biomarkers for this phenomenon are a likely field of study in order to confirm diagnosis. This review highlights the current proteomics studies that investigated excessively nitrated proteins and those altered by lipid peroxidation in TBI. This review also highlights possible diagnostic measures and provides insights for future treatment strategies.
引用
收藏
页码:1191 / 1204
页数:14
相关论文
共 123 条
[21]  
Butterfield DA, 2012, ANTIOXID REDOX SIGN, V17, P1610, DOI 10.1089/ars.2011.4109
[22]   Protein-bound acrolein: A novel marker of oxidative stress in Alzheimer's disease [J].
Calingasan, NY ;
Uchida, K ;
Gibson, GE .
JOURNAL OF NEUROCHEMISTRY, 1999, 72 (02) :751-756
[23]  
Carroll Linda J, 2014, Arch Phys Med Rehabil, V95, pS152, DOI 10.1016/j.apmr.2013.08.300
[24]  
Cassidy J David, 2014, Arch Phys Med Rehabil, V95, pS132, DOI 10.1016/j.apmr.2013.08.299
[25]   Proteomic identification of nitrated proteins in Alzheimer's disease brain [J].
Castegna, A ;
Thongboonkerd, V ;
Klein, JB ;
Lynn, B ;
Markesbery, WR ;
Butterfield, DA .
JOURNAL OF NEUROCHEMISTRY, 2003, 85 (06) :1394-1401
[26]   Isobaric tags for relative and absolute quantitation (iTRAQ) reproducibility: Implication of multiple injections [J].
Chong, PK ;
Gan, CS ;
Pham, TK ;
Wright, PC .
JOURNAL OF PROTEOME RESEARCH, 2006, 5 (05) :1232-1240
[27]   Blocking leukotriene synthesis attenuates the pathophysiology of traumatic brain injury and associated cognitive deficits [J].
Corser-Jensen, Chelsea E. ;
Goodell, Dayton J. ;
Freund, Ronald K. ;
Serbedzija, Predrag ;
Murphy, Robert C. ;
Farias, Santiago E. ;
Dell'Acqua, Mark L. ;
Frey, Lauren C. ;
Serkova, Natalie ;
Heidenreich, Kim A. .
EXPERIMENTAL NEUROLOGY, 2014, 256 :7-16
[28]   Local Glutamate Level Dictates Adenosine A2A Receptor Regulation of Neuroinflammation and Traumatic Brain Injury [J].
Dai, Shuang-Shuang ;
Zhou, Yuan-Guo ;
Li, Wei ;
An, Jian-Hong ;
Li, Ping ;
Yang, Nan ;
Chen, Xing-Yun ;
Xiong, Ren-Ping ;
Liu, Ping ;
Zhao, Yan ;
Shen, Hai-Ying ;
Zhu, Pei-Fang ;
Chen, Jiang-Fan .
JOURNAL OF NEUROSCIENCE, 2010, 30 (16) :5802-5810
[29]   Nitrotyrosine as an oxidative stress marker: Evidence for involvement in neurologic outcome in human traumatic brain injury [J].
Darwish, Ribal S. ;
Amiridze, Nana ;
Aarabi, Bizhan .
JOURNAL OF TRAUMA-INJURY INFECTION AND CRITICAL CARE, 2007, 63 (02) :439-442
[30]  
Dehairs Jonas, 2015, Drug Discov Today Technol, V13, P33, DOI 10.1016/j.ddtec.2015.03.002